Literature DB >> 7085215

Autoregulation of the retinal circulation in response to decrease of intraocular pressure below normal.

J E Grunwald, S H Sinclair, C E Riva.   

Abstract

The autoregulatory response of the retinal circulation to a short-term reduction in intraocular pressure (IOP) to hypotonic levels was studied in 15 normal subjects by means of the blue-field entoptic phenomenon. This phenomenon allows the perception of the leukocytes flowing in one's own retinal macular capillaries. Subjects were asked to compare the leukocyte speed in one eye with that in the fellow eye while a scleral suction cup was used to raise the IOP in one eye to levels above 25 mm Hg for approximately 12 min. The release of the suction cup caused a drop in IOP to levels between 4 and 7 mm Hg, at which time all subjects reported a higher leukocyte speed (hyperemia) in this eye than in the fellow eye. After an average of 4 min the speed was observed to be equal in both eyes. The average IOP at which the equalization occurred was 6.8 +/- 1.3 mm Hg. The retina can therefore normalize leukocyte capillary speed and presumably blood flow at IOPs at least as low as 6.8 mm Hg. The results of 16 experiments on the same eye of one subject suggest that under these experimental conditions, the lowest IOP for which the retina can fully autoregulate is around 6 to 7 mm Hg.

Entities:  

Mesh:

Year:  1982        PMID: 7085215

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Effect of oral felodipine on ocular circulation.

Authors:  L S Schocket; J E Grunwald; J Dupont
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

2.  Non-invasive vascular impedance measures demonstrate ocular vasoconstriction during isometric exercise.

Authors:  Andrew J Morgan; Sarah L Hosking
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

3.  A laser Doppler velocimetry study of the effect of hypoglycaemia on retinal blood flow in the minipig.

Authors:  G Caldwell; E G Davies; P M Sullivan; A H Morris; E M Kohner
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

4.  Retinal perfusion 6 months after trabeculectomy as measured by optical coherence tomography angiography.

Authors:  C Lommatzsch; K Rothaus; J M Koch; C Heinz; S Grisanti
Journal:  Int Ophthalmol       Date:  2019-05-09       Impact factor: 2.031

5.  Fundus pulsation measurements in diabetic retinopathy.

Authors:  L Schmetterer; A Salomon; A Rheinberger; C Unfried; F Lexer; M Wolzt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-05       Impact factor: 3.117

6.  Prolonged retinal arteriovenous passage time is correlated to ocular perfusion pressure in normal tension glaucoma.

Authors:  Niklas Plange; Marion Kaup; Andreas Remky; Kay Oliver Arend
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-02       Impact factor: 3.117

7.  The effect of latanoprost on ocular blood flow.

Authors:  Alon Harris; Hanna J Garzozi; Lynne McCranor; Ehud Rechtman; Chi-Wah Yung; Brent Siesky
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

8.  Intravenous administration of clonidine reduces intraocular pressure and alters ocular blood flow.

Authors:  Günther Weigert; Hemma Resch; Alexandra Luksch; Herbert A Reitsamer; Gabriele Fuchsjager-Mayrl; Leopold Schmetterer; Gerhard Garhofer
Journal:  Br J Ophthalmol       Date:  2007-05-30       Impact factor: 4.638

9.  Effect of systemic blood pressure on optical coherence tomography angiography in glaucoma patients.

Authors:  Chan Keum Park; Kwanghyun Lee; Eun Woo Kim; Sangah Kim; Sang Yeop Lee; Chan Yun Kim; Gong Je Seong; Hyoung Won Bae
Journal:  Eye (Lond)       Date:  2020-10-01       Impact factor: 4.456

Review 10.  Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure.

Authors:  Luciano Quaranta; Ivano Riva; Andreas Katsanos; Irene Floriani; Marco Centofanti; Anastasios G P Konstas
Journal:  Clin Ophthalmol       Date:  2015-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.